13 Jun 2024
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/cara-therapeutics-discontinues-study-neurological-condition-drug-fails-2024-06-12/
12 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/12/2897873/29236/en/Cara-Therapeutics-Announces-Outcome-of-Part-A-of-KOURAGE-1-Study-Evaluating-Oral-Difelikefalin-in-Notalgia-Paresthetica.html
18 Dec 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/12/18/2797670/29236/en/Cara-Therapeutics-Announces-Outcome-from-Dose-Finding-Part-A-of-KIND-1-Study-Evaluating-Oral-Difelikefalin-for-Moderate-to-Severe-Pruritus-in-Patients-with-Atopic-Dermatitis.html
19 May 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/kapruvia-difelikefalin-recommended-by-englands-nice-for-the-treatment-of-adults-with-moderate-to-severe-ckd-associated-pruritus-301827524.html
18 May 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/05/18/2671614/29236/en/Kapruvia-difelikefalin-recommended-by-England-s-NICE-for-the-treatment-of-adults-with-moderate-to-severe-CKD-associated-pruritus.html
28 Sep 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/09/28/2524125/29236/en/Cara-Therapeutics-Announces-Difelikefalin-KORSUVA-Injection-New-Drug-Application-Has-Been-Submitted-in-Japan.html
LOOKING FOR A SUPPLIER?